Rossari Biotech Ltd
Next 500 2024
+ 3 More
+ 3 More
Share
Share
OVERVIEW
FINANCIALS
NEWS
Featured In Fortune India Ranking
Next 500 India
#339(2024)#240(2023)#387(2022)#474(2021)
#339(2024)#240(2023)#387(2022)#474(2021)
Financial Data 2024
Revenue
1,902
(INR Cr)
Net Operating Income
1,831
(INR Cr)
Assets
1,171
(INR Cr)
Profit
131
(INR Cr)
Net Worth
1,048
(INR Cr)
Fortune India Coverage
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 1902 13.5% | 1675 10.4% | 1517 108.7% | 727 20.9% | 601 12.8% | 533 81.7% | 293 25.1% | 235 36.4% | 172 16.2% | 148 4.8% | 141 24.1% | 114 -4.6% | 119 -2.3% | 122 - |
| Net Operating Income (INR Cr) | 1831 10.55% | 1656 11.66% | 1483 109.06% | 709 18.21% | 600 16.25% | 516 0.00% | 292 25.03% | 233 31.05% | 178 15.91% | 154 11.95% | 137 25.37% | 109 -7.13% | 118 -3.14% | 122 0.00% |
| Profit (INR Cr) | 131 21.8% | 107 9.8% | 98 21.8% | 80 22.9% | 65 42.8% | 46 58.0% | 29 85.5% | 16 355.9% | 3 -7.3% | 4 1.9% | 4 13.5% | 3 -36.6% | 5 -1.4% | 5 - |
| Assets (INR Cr) | 1171 17.1% | 999 10.9% | 902 120.0% | 410 15.4% | 355 166.9% | 133 16.5% | 114 30.7% | 87 30.1% | 67 -19.0% | 83 3.0% | 81 3.1% | 78 4.3% | 75 8.1% | 69 - |
| Net Worth (INR Cr) | 1048 14.5% | 915 13.7% | 805 97.0% | 409 42.6% | 287 131.6% | 124 0.0% | 90 47.7% | 61 33.9% | 45 7.5% | 42 -3.1% | 43 20.3% | 36 8.1% | 33 5.5% | 32 0.0% |
| Employee Cost (INR Cr) | 103 4.6% | 99 45.2% | 68 61.8% | 42 12.8% | 37 35.2% | 28 40.9% | 20 38.2% | 14 23.5% | 11 6.3% | 11 4.3% | 10 46.2% | 7 15.0% | 6 34.4% | 5 - |
| Interest Cost (INR Cr) | 19 | 22 | 13 | 3 | 4 | 3 | 1 | 2 | 3 | 4 | 5 | 5 | 5 | 3 |
| Cash & Bank Balance (INR Cr) | 30 | 124 | 52 | 88 | 127 | 6 | 1 | 2 | 2 | 1 | 0 | 1 | 0 | 0 |
| Total Debt (INR Cr) | 119 | 74 | 8 | 0 | 67 | 8 | 22 | 24 | 22 | 41 | 37 | 42 | 41 | 38 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 6.9% | 6.4% | 6.4% | 11.0% | 10.9% | 8.6% | 9.9% | 6.7% | 2.0% | 2.5% | 2.6% | 2.8% | 4.2% | 4.2% |
| Profit As % Of Assets | 11.2% | 10.7% | 10.8% | 19.6% | 18.4% | 34.3% | 25.3% | 17.8% | 5.1% | 4.5% | 4.5% | 4.1% | 6.7% | 7.4% |
| Profit As % Of Networth | 12.5% | 11.7% | 12.1% | 19.6% | 22.8% | 36.9% | 32.3% | 25.7% | 7.6% | 8.8% | 8.3% | 8.8% | 15.1% | 16.1% |
| Interest Cost to EBITDA % | 7.8% | 10.0% | 6.9% | 2.4% | 3.4% | 3.7% | 3.0% | 8.7% | 27.9% | 32.0% | 34.8% | 35.8% | 32.7% | 23.8% |
| Debt to Equity Ratio | 0.11 | 0.08 | 0.01 | - | 0.23 | 0.06 | 0.24 | 0.40 | 0.49 | 0.97 | 0.85 | 1.16 | 1.24 | 1.19 |
| RONW | 13.3% | 12.5% | 16.1% | 23.0% | 31.8% | 36.9% | 38.5% | 29.5% | 7.8% | 8.6% | 9.1% | 9.2% | 15.1% | 16.1% |
| ROCE | 18.2% | 17.5% | 22.7% | 28.7% | 37.4% | 49.8% | 40.4% | 27.0% | 11.0% | 11.0% | 11.1% | 10.4% | 15.1% | 12.8% |